Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NSE India Stock Exchange  >  Sun Pharmaceutical Industries Ltd.    SUNPHARMA   INE044A01036

SUN PHARMACEUTICAL INDUSTRIES LTD.

(SUNPHARMA)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Nse India Stock Exchange
07/03/2020 07/06/2020 07/07/2020 07/08/2020 07/09/2020 Date
476.85 480.2 479.25 482.5 481.95 Last
4666366 5995308 6793461 6279478 3184423 Volume
+0.81% +0.70% -0.20% +0.68% -0.11% Change
Financials
Sales 2020 326 B 4 332 M 4 332 M
Net income 2020 43 229 M 574 M 574 M
Net cash position 2020 34 960 M 464 M 464 M
P/E ratio 2020 26,8x
Yield 2020 0,58%
Sales 2021 355 B 4 717 M 4 717 M
Net income 2021 46 613 M 619 M 619 M
Net cash position 2021 61 559 M 818 M 818 M
P/E ratio 2021 24,5x
Yield 2021 0,62%
Capitalization 1 156 B 15 393 M 15 360 M
EV / Sales 2020 3,44x
EV / Sales 2021 3,08x
Nbr of Employees 32 000
Free-Float 43,9%
More Financials
Company
Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows: - generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment; - active pharmaceutical ingredients (6%). At the end of March 2019, the group had 44 production plants worldwide. Net sales... 
Sector
Pharmaceuticals
Calendar
08/18Earnings Release
More about the company
Surperformance© ratings of Sun Pharmaceutical Industr
Trading Rating : Investor Rating :
More Ratings
Latest news on SUN PHARMACEUTICAL INDUSTR
06/30SUN PHARMACEUTICAL INDUSTRIES : Pharma announces Japan MHLW approval of ILUMYA f..
AQ
06/25India's auto and pharma sectors not ready to wean off China
RE
06/25India's auto and pharma sectors not ready to wean off China
RE
06/25SUN PHARMACEUTICAL INDUSTRIES : Pharma Announces Pre-Clinical Data on GL0034June..
AQ
06/16HIKMA PHARMACEUTICALS : and Sun Pharma enter into exclusive licensing agreement ..
AQ
06/15SUN PHARMACEUTICAL INDUSTRIES : Pharma Announces Long-term Insights into the Cli..
AQ
06/15SUN PHARMACEUTICAL INDUSTRIES : Pharma Presents ODOMZO and LEVULAN KERASTICK + B..
AQ
06/15SUN PHARMACEUTICAL INDUSTRIES : Pharma Announces Long-term Insights into the Cli..
AQ
06/08SUN PHARMACEUTICAL INDUSTRIES : Pharma initiates Phase II clinical trial on AQCH..
AQ
06/01SUN PHARMACEUTICAL INDUSTRIES : Pharma receives approval from DCGI to initiate c..
AQ
05/29SUN PHARMA ADVANCED RESEARCH : Press Release Sun Pharma and SPARC enter into a w..
AQ
05/27SUN PHARMACEUTICAL INDUSTRIES LTD. : Annual results
CO
05/22SUN PHARMACEUTICAL INDUSTRIES LTD. : annual earnings release
05/20SUN PHARMACEUTICAL INDUSTRIES : Pharma to announce fourth quarter results on May..
AQ
05/07GSK sells $3.4 billion Hindustan Unilever stake in largest India block trade
RE
More news
News in other languages on SUN PHARMACEUTICAL INDUSTR
06/30SUN PHARMACEUTICAL INDUSTRIES : Pharma announces Japan MHLW approval of ILUMYA f..
06/25India's auto and pharma sectors not ready to wean off China
06/25India's auto and pharma sectors not ready to wean off China
06/25SUN PHARMACEUTICAL INDUSTRIES : Pharma Announces Pre-Clinical Data on GL0034June..
06/16HIKMA PHARMACEUTICALS : and Sun Pharma enter into exclusive licensing agreement ..
More news
Chart SUN PHARMACEUTICAL INDUSTRIES LTD.
Duration : Period :
Sun Pharmaceutical Industries Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SUN PHARMACEUTICAL INDUSTR
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 31
Average target price 501,48 INR
Last Close Price 481,95 INR
Spread / Highest target 28,6%
Spread / Average Target 4,05%
Spread / Lowest Target -24,3%
EPS Revisions
Managers
NameTitle
Dilip Shantilal Shanghvi Managing Director & Executive Director
Israel Makov Non-Executive Chairman
C. S. Muralidharan Chief Financial Officer
Atanu Roy SVP & Chief Information Officer
Sudhir Vrundavandas Valia Non-Executive Non-Independent Director